ARKG vs SPXU

ARK Genomic Revolution ETF vs ProShares UltraPro Short S&P500

Quick take
  • • ARKG has the lower expense ratio at 0.75% vs 0.90% for SPXU.
  • • SPXU pays a higher dividend yield (6.05%).

Side-by-side metrics

MetricARKGSPXU
Expense ratio
Annual fee. Lower is better.
0.75%0.90%
Dividend yield
Trailing 12-month yield.
0.00%6.05%
AUM
Assets under management — bigger funds are typically more liquid.
$2.21B$428M
YTD return
66.55%-25.45%
1-year return
——
3-year return
Annualized.
——
5-year return
Annualized.
——
10-year return
Annualized.
——
Beta (3Y)
Volatility relative to the market. Closer to 1 = market-like.
2.11-2.62
P/E ratio
——
Last price
$47.17$34.75
Inception
——
Issuer
ARKProShares

ARKG top holdings

Top holdings · ARKG
TWSTTwist Bioscience Corp8.75%
TXG10x Genomics Inc Ordinary Shares - Class A8.73%
TEMTempus AI Inc Class A common stock8.36%
ABSIAbsci Corp5.56%
CRSPCRISPR Therapeutics AG5.22%
GHGuardant Health Inc4.88%
NTRANatera Inc4.71%
ILMNIllumina Inc4.69%
LLYEli Lilly and Co3.92%
BEAMBeam Therapeutics Inc3.69%
Sector breakdown · ARKG
Healthcare100.0%

SPXU top holdings

Top holdings · SPXU
IQMMProShares GENIUS Money Market ETF89.37%

About ARKG

ARKG (ARK Genomic Revolution ETF) is Companies advancing genomics and molecular biology. Managed by ARK, the fund carries $2.2B in assets under management, an expense ratio of 0.75%. Its largest holding is Twist Bioscience Corp (TWST), which represents 8.7% of the portfolio. Healthcare is the fund's largest sector exposure at 100.0%.

About SPXU

SPXU (ProShares UltraPro Short S&P500) is 3x inverse daily performance of the S&P 500. Managed by ProShares, the fund carries $428M in assets under management, an expense ratio of 0.90%, a dividend yield of 6.05%. Its largest holding is ProShares GENIUS Money Market ETF (IQMM), which represents 89.4% of the portfolio.